Samil Pharmaceutical Co., Ltd. (000520) Price & Analysis

― Followers

000520 Stock Chart & Stats

₩6380.00

₩160.00(2.57%)

Aug 20, 2026

―

Day’s Range― - ―

52-Week Range₩5,500.00 - ₩12,860.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)91.98K

Market Cap

₩134.04B

Enterprise Value₩310.98K

Total Cash (Recent Filing)₩6.11B

Total Debt (Recent Filing)₩176.05B

Price to Earnings (P/E)―

Beta0.05

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1763.67

Shares Outstanding21,691,810

10 Day Avg. Volume85,383

30 Day Avg. Volume91,980

Financial Highlights & Ratios

PEG Ratio-0.01

Price to Book (P/B)1.54

Price to Sales (P/S)0.98

P/FCF Ratio-15.23

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

000520 FAQ

What was Samil Pharmaceutical Co., Ltd.’s price range in the past 12 months?

Samil Pharmaceutical Co., Ltd. lowest stock price was ₩5500.00 and its highest was ₩12860.00 in the past 12 months.

What is Samil Pharmaceutical Co., Ltd.’s market cap?

Samil Pharmaceutical Co., Ltd.’s market cap is ₩134.04B.

When is Samil Pharmaceutical Co., Ltd.’s upcoming earnings report date?

Samil Pharmaceutical Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 88 days.

How were Samil Pharmaceutical Co., Ltd.’s earnings last quarter?

Samil Pharmaceutical Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩359.853 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Samil Pharmaceutical Co., Ltd. overvalued?

According to Wall Street analysts Samil Pharmaceutical Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Samil Pharmaceutical Co., Ltd. pay dividends?

Samil Pharmaceutical Co., Ltd. pays a N/A dividend of ₩72.727 which represents an annual dividend yield of N/A. See more information on Samil Pharmaceutical Co., Ltd. dividends here

What is Samil Pharmaceutical Co., Ltd.’s EPS estimate?

Samil Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Samil Pharmaceutical Co., Ltd. have?

Samil Pharmaceutical Co., Ltd. has 21,691,810 shares outstanding.

What happened to Samil Pharmaceutical Co., Ltd.’s price movement after its last earnings report?

Samil Pharmaceutical Co., Ltd. reported an EPS of -₩359.853 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.442%.

Which hedge fund is a major shareholder of Samil Pharmaceutical Co., Ltd.?

Currently, no hedge funds are holding shares in KR:000520

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Samil Pharmaceutical Co., Ltd.

Samil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company founded in 1947 that develops, manufactures, and sells a range of healthcare products. While its portfolio includes various medicines and medical devices, it has a particular specialization in ophthalmology (eye care). The company engages in the development of new drugs and also provides Contract Development and Manufacturing Organisation (CDMO) services.